SELLAS Life Sciences (SLS) Granted Fast Track Designation from FDA for Galinpepimut-S for Treatment of Patients with Multiple Myeloma
Tweet Send to a Friend
SELLAS Life Sciences Group Inc. (NASDAQ: SLS) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE